With equal access, African Americans have superior survival compared to Caucasians with Multiple Myeloma: a VA study

TO THE EDITOR: Multiple myeloma (MM) constitutes 1.8% of malignancies in the United States, and its incidence is significantly higher among African Americans (AAs) than whites.[1][1],[2][2] Therefore, the impact of race on the disease biology and clinical outcomes of MM is an important area of